📰 Merck Sharp News
Page 34 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
June 2, 2023
Dupree v. Younger, ___ S. Ct. ___, 2023 WL 3632755 (U.S. May 25, 2023), has nothing whatever to do with drugs, or devices, or product liability, but…
June 1, 2023
The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in stage III and IV
May 31, 2023
The CTLA-4 inhibitors pipeline and clinical trial analysis report deliver important insights on ongoing research, clinical strategies, upcoming therapeutics, and commercial analysis. LAS
May 31, 2023
Healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
May 31, 2023
/PRNewswire/ -- DelveInsights CTLA-4 Inhibitors Competitive Landscape – 2023 report provides comprehensive global coverage of available, marketed, and...
May 30, 2023
/PRNewswire/ -- DelveInsights Parkinsons Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinsons...
May 30, 2023
DelveInsight's analysts estimate that the Parkinson's disease market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of novel therapies
May 25, 2023
UC Riverside-led study focused on older people living with HIV during the pandemic
May 24, 2023
DelveInsight's analysts estimate that relapsed/refractory acute myeloid leukemia market is poised to show significant growth, mainly attributed to recent drug approvals, increasing incidence,
May 23, 2023
/PRNewswire/ -- Eisai announced today the presentation of research across various types of cancer from its oncology portfolio and pipeline during the 2023...